Sign Up to like & get recommendations! 2
Published in 2023 at "Advanced science"
DOI: 10.1002/advs.202207455
Abstract: Recent global events such as COVID-19 pandemic amid rising rates of chronic lung diseases highlight the need for safer, simpler, and more available treatments for respiratory failure, with increasing interest in extracorporeal membrane oxygenation (ECMO).… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28375
Abstract: Transcatheter aortic valve implantation (TAVI) has become a well‐established therapeutic option for patients with severe aortic stenosis (AS) at high to intermediate surgical risk. Although TAVI is associated with low mortality of 1.2–6.5%, cardiogenic shock… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30230
Abstract: To assess the outcomes of a single‐center experience with percutaneous left ventricular assist device (LVAD) decommissioning. read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13267
Abstract: Left ventricular assist device therapy has become the cornerstone in the treatment of end‐stage heart failure and is increasingly used as destination therapy next to bridge to transplant or recovery. HeartMate 3 (HM3) and HeartWare… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13769
Abstract: We report the first case of an investigational maglev extracorporeal ventricular assist device (extra‐VAD) use in China for a patient with cardiogenic shock post‐coronary artery bypass surgery. There were no extra‐VAD devices available for clinical… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13798
Abstract: To assess the 6 months immunogenicity to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mRNA vaccine in a population of heart transplanted (HTx) recipients and left ventricular assist device (LVAD)‐supported patients. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13951
Abstract: The removal of left ventricular assist device (LVAD) after myocardial recovery can provide survival benefits with freedom from LVAD‐associated complications. However, in the absence of standardization, the weaning evaluation and surgical strategy differ widely among… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "ESC heart failure"
DOI: 10.1002/ehf2.14366
Abstract: AIMS Phosphodiesterase-5 inhibitors (PDE5I) are frequently implemented after left ventricular assist device (LVAD) implantation to improve haemodynamics in patients with early postoperative right ventricular (RV) failure. It is unknown if long-term PED5I therapy beyond the… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "ESC Heart Failure"
DOI: 10.1002/ehf2.15063
Abstract: Although left ventricular assist device (LVAD) implantation improves prognosis of advanced heart failure patients still suffer from impaired exercise capacity and quality of life (QoL). Exercise training may improve both; however, the available evidence about… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "ESC Heart Failure"
DOI: 10.1002/ehf2.15282
Abstract: Patients with acute decompensated advanced heart failure requiring left ventricular assist device (LVAD) implantation often experience progressive cardiac function deterioration, negatively impacting surgical outcomes. This study aimed to assess the efficacy of different microaxial flow… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2761
Abstract: This article refers to ‘Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis’ by N. Uriel et al. , published in… read more here.